Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


CLARKE JOHN K Create: Alert

All | News | Filings
Date FiledTypeDescription
05/19/2023 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 12,000 options to buy @ $2.52, valued at $30.2k
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2022 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 6,000 restricted stock units @ $0
05/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2020 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Sold 100 shares @ $4, valued at $400
Sold 7,260 shares @ $4.01, valued at $29.1k
08/28/2020 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Sold 2,200 shares @ $4.296, valued at $9.5k
Sold 5,440 shares @ $4.09, valued at $22.2k
05/08/2020 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 1,428 options to buy @ $3.65, valued at $5.2k
05/10/2019 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 20,000 options to buy @ $0.5834, valued at $11.7k
06/22/2018 4 CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 9,000 options to buy @ $105.26, valued at $947.3k
06/04/2018 4 CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Sold 2,758 shares @ $99.38, valued at $274.1k
Sold 10,042 shares @ $100.33, valued at $1M
Sold 2,100 shares @ $101.37, valued at $212.9k
Sold 100 shares @ $101.97, valued at $10.2k
Exercised 15,000 options to buy @ $27.28, valued at $409.2k
05/17/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/11/2017 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
06/07/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/26/2016 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 18,000 options to buy @ $3.33, valued at $59.9k
01/29/2016 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 19,428 options to buy @ $6.14, valued at $119.3k
07/10/2015 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 6,286 options to buy @ $14.96, valued at $94k
06/11/2015 4 CLARKE JOHN K (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC
Txns: Granted 17,750 options to buy @ $22.18, valued at $393.7k
06/03/2015 4 CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 11,250 options to buy @ $131.21, valued at $1.5M
05/14/2015 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Converted 92,306 shares @ $0
Converted 1,758,158 shares @ $0
Converted 893,655 options to buy @ $0
Converted 2,400,000 options to buy @ $0
Converted 3,600,000 options to buy @ $0
Converted 4,320,173 options to buy @ $0
Converted 2,127,660 options to buy @ $0
Converted 1,536,787 options to buy @ $0
05/14/2015 4 CLARKE JOHN K (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC
Txns: Sold 38,400 shares @ $19.96, valued at $766.5k
Exercised 38,400 options to buy @ $10.44, valued at $400.9k
06/13/2014 4 CLARKE JOHN K (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC
Txns: Granted 17,750 options to buy @ $13.16, valued at $233.6k
06/06/2014 4 CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 15,000 options to buy @ $59.25, valued at $888.8k
05/23/2014 4 CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Sold 22,792 shares @ $52.954, valued at $1.2M
Sold 2,500 shares @ $54.2142, valued at $135.5k
Sold 6,908 shares @ $55.4684, valued at $383.2k
Sold 2,800 shares @ $56.1929, valued at $157.3k
Exercised 10,000 options to buy @ $7.08, valued at $70.8k
Exercised 10,000 options to buy @ $14.74, valued at $147.4k
Exercised 15,000 options to buy @ $15.91, valued at $238.7k
06/13/2013 4 CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc.
Txns: Bought 23,171 shares @ $9.5993, valued at $222.4k
06/13/2013 4 CLARKE JOHN K (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC
Txns: Granted 17,750 options to buy @ $14.42, valued at $256k
06/12/2013 4 CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc.
Txns: Bought 25,000 shares @ $9.2191, valued at $230.5k
06/10/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
06/06/2013 4 CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc.
04/19/2013 4 CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc.
06/25/2012 4 CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns: Granted 15,000 options to buy @ $11.33, valued at $170k
06/15/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
03/08/2012 4 CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy